Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AMG-119 by Amgen for Small-Cell Lung Cancer: Likelihood of Approval
AMG-119 is under clinical development by Amgen and currently in Phase I for Small-Cell Lung Cancer. According to GlobalData, Phase...